Published ahead of print on May 5, 2005, doi:10.1165/rcmb.2005-0005OC
© 2005 American Thoracic Society DOI: 10.1165/rcmb.2005-0005OC The Effect of Cyclosporin A on Airway Cell Proinflammatory Signaling and PneumoniaDepartment of Pediatrics and Pharmacology, Columbia University, New York, New York Correspondence and requests for reprints should be addressed to Dr. Alice Prince, Department of Pediatrics, Columbia University, 650 West 168th Street, New York, NY 10032. E-mail: asp7{at}columbia.edu
Cyclosporin A (CsA) blocks T cell activation by interfering with the Ca2+-dependent phosphatase, calcineurin. Proinflammatory responses to bacteria that are activated by Ca2+-fluxes in airway cells are a potential target for CsA. Although local immunosuppression may be advantageous to control airway inflammation, it could also increase susceptibility to bacterial pneumonia and invasive infection. As aerosolized CsA is currently under study in lung transplantation, we examined its direct effects on airway cells as well as in a murine model of pneumonia. Epithelial interleukin-6 production was very effectively inhibited by CsA, whereas CXCL8 production, the major PMN chemokine, was only modestly diminished. Responses to a TLR2 agonist Pam3Cys were more sensitive to CsA inhibition than those activated by Pseudomonas aeruginosa. CsA substantially blocked activation of nuclear factor of activated T cells and cAMP-responsive elementbinding protein (P < 0.001), inhibited CCAAT/enhancer-binding protein by 50% (P < 0.05), and minimally blocked activator protein-1 and nuclear factor-
Key Words: cyclosporin A Pseudomonas aeruginosa airway cells pneumonia aerosol This article has been cited by other articles:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||